Forbes June 14, 2024
Lefkofsky, the founder and CEO of Tempus, spoke with Forbes about the IPO and the company, which is built on a massive trove of AI-trained patient and genomic data.
Five years ago, Chicago-based billionaire and serial entrepreneur Eric Lefkofsky told Forbes he hoped health analytics and precision medicine company Tempus AI would be his “legacy project.” It’s currently his most valuable asset—and his fourth company to go public.
Shares of the company were priced on the Nasdaq on Thursday at $37 per share and started trading on Friday, giving Tempus a market capitalization of $6.1 billion, lower than Tempus’ last private valuation of $8.5 billion from a 2022 funding round. Lefkofsky, who is founder and CEO, holds an estimated 33%...
Today's Sponsors
Today's Sponsor